← Leaderboards
Lisa Rimsza
University Of Rochester
$10,310,313
Attributed
$16,285,950
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,523,943 · 8
By mechanism
P01$11,414,331 · 2
UM1$8,686,983 · 1
U01$3,062,767 · 1
P50$1,572,172 · 1
UH3$1,021,903 · 1
UH2$765,787 · 2
Top collaborators
- Andrew Lewis Feldman3 shared
- David William Scott3 shared
- Jeffrey M Bethony2 shared
- James R Cerhan2 shared
- Anna Coghill2 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Gary R Morrow$66,207,520
- Bradford C Berk$28,468,508
- Cynthia M Rand$5,059,512
- Edward G Freedman$10,656,621
- Wojciech Zareba$21,736,071
Others in their field
Top investigators on “Lymphoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
- Richard L Schilsky · University Of Chicago$120,036,663
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
- Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
- Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
- Charles A Coltman · Southwest Oncology Group$55,198,633
Research focus
LymphomaProgramsDiagnosisTissuesDiagnosticClinical TrialsEnsurePathologicSiteLaboratoriesEvaluationMalignant NeoplasmsResourcesBiopsyMolecularFreezingTherapeutic TargetMolecular DiagnosisLeukemia/LymphomaPrincipal InvestigatorResearch PersonnelBaseLeadershipMolecular Profiling
Grant awards (29)
AIDS and Cancer Specimen Resource (ACSR)$3,963,281
UM1 · FY2025 · CA
Assay Development and Prognostic Model for Predicting Early Clinical Failure in Follicular Lymphoma$161,663
UH2 · FY2025 · CA · contact PI
AIDS and Cancer Specimen Resource (ACSR)$4,723,702
UM1 · FY2024 · CA
Assay Development and Prognostic Model for Predicting Early Clinical Failure in Follicular Lymphoma$206,968
UH2 · FY2024 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$1,913,660
P01 · FY2022 · CA · contact PI
Administrative Core$176,422
P01 · FY2022 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,117,897
P01 · FY2021 · CA · contact PI
Development of Mantle Cell Lymphoma Proliferation Signature Assay$344,075
UH3 · FY2021 · CA · contact PI
Administrative Core$276,090
P01 · FY2021 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,112,284
P01 · FY2020 · CA · contact PI
Development of Mantle Cell Lymphoma Proliferation Signature Assay$344,075
UH3 · FY2020 · CA · contact PI
Administrative Core$276,090
P01 · FY2020 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,006,791
P01 · FY2019 · CA · contact PI
Development of Mantle Cell Lymphoma Proliferation Signature Assay$333,753
UH3 · FY2019 · CA · contact PI
Administrative Core$173,134
P01 · FY2019 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,087,361
P01 · FY2018 · CA · contact PI
Administrative Core$274,602
P01 · FY2018 · CA · contact PI
Development of Mantle Cell Lymphoma Proliferation Signature Assay$198,578
UH2 · FY2018 · CA · contact PI
Development of Mantle Cell Lymphoma Proliferation Signature Assay$198,578
UH2 · FY2017 · CA · contact PI
Molecular Diagnosis and Prognosis in Aggressive Lymphoma$841,820
U01 · FY2015 · CA · contact PI
Molecular Diagnosis and Prognosis in Aggressive Lymphoma$565,864
U01 · FY2014 · CA · contact PI
Molecular Diagnosis and Prognosis in Aggressive Lymphoma$460,703
U01 · FY2013 · CA · contact PI
Molecular Diagnosis and Prognosis in Aggressive Lymphoma$594,380
U01 · FY2012 · CA · contact PI
CB: Tissue Core$323,641
P50 · FY2012 · CA · contact PI
Molecular Diagnosis and Prognosis in Aggressive Lymphoma$600,000
U01 · FY2011 · CA · contact PI
CB: Tissue Core$306,944
P50 · FY2011 · CA · contact PI
CB: Tissue Core$323,443
P50 · FY2010 · CA · contact PI
CB: Tissue Core$363,518
P50 · FY2009 · CA · contact PI
CB: Tissue Core$254,626
P50 · FY2008 · CA · contact PI